Skip to content

Aaris Acrylic Intraocular lens(IOL) EC-3 PAL (UDI 00884872025404)Recalls & reported problems

Aaren Scientific Inc. · Class 3 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00884872025404), received between May 5, 2016 and May 5, 2016 — classified as 1 injury.

The most frequently reported specific device problem is “Detachment Of Device Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Detachment Of Device Component1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 5, 2016Detachment Of Device Component; Detachment Of Device Component

    IT WAS REPORTED THAT DURING A PROCEDURE, IT WAS NOTED THAT THE TRAILING HAPTIC BROKE OFF WHEN THE LENS WAS BEING INSERTED INTO THE EYE AND REMAINED STUCK INSIDE THE INJECTOR. THE LENS WAS EXPLANTED, THE WOUND WAS ENLARGED TO REMOVE THE LENS, AND SUTURES USED TO CLOSE THE WOUND. NO POSTERIOR OR ANTERIOR CAPSULE TEAR WAS REPORTED. ANOTHER LENS WAS IMPLANTED TO SUCCESSFULLY COMPLETE THE PROCEDURE. THERE WERE NO REPORTED ADVERSE PATIENT SEQUELAE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 5636084 ↗

Other Intraocular Lens devices

All Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page